Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.
Nissen SE; Wolski K; Topol EJ; JAMA, 2005, vol. 294, issue 20, p 2581, ISSN 15383598. ISBN 15383598.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef